Phase Ib Study of Copanlisib in Combination With Nivolumab or With Nivolumab and Ipilimumab
NCT03502733 · ACTIVE NOT RECRUITING · Phase 1
ReadTheTrial indexes 1 studies for Lymphoma. The most common development stage is Phase 1 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.
1 clinical trials found for Lymphoma.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 1 | 100% |
There are 1 clinical trials listed for Lymphoma. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Lymphoma trials are distributed across: Phase 1 (1).